A Phase I/II Clinical Trial of Belinostat (PXD101) in Combination with Doxorubicin in Patients with Soft Tissue Sarcomas. (Q37043932)
Jump to navigation
Jump to search
scientific article published on 14 June 2016
Language | Label | Description | Also known as |
---|---|---|---|
English | A Phase I/II Clinical Trial of Belinostat (PXD101) in Combination with Doxorubicin in Patients with Soft Tissue Sarcomas. |
scientific article published on 14 June 2016 |
Statements
A Phase I/II Clinical Trial of Belinostat (PXD101) in Combination with Doxorubicin in Patients with Soft Tissue Sarcomas (English)
Philip Blach Rossen
Maja Lind-Hansen
1 January 2016
1 reference
1 reference